Once-weekly carfilzomib, pomalidomide, and low-dose dexamethasone for relapsed/refractory myeloma: a phase I/II study
Bringhen, Sara, Mina, Roberto, Cafro, Anna Maria, Liberati, Anna Marina, Spada, Stefano, Belotti, Angelo, Gaidano, Gianluca, Patriarca, Francesca, Troia, Rossella, Fanin, Renato, De Paoli, Lorenzo, RoLanguage:
english
Journal:
Leukemia
DOI:
10.1038/s41375-018-0024-1
Date:
January, 2018
File:
PDF, 443 KB
english, 2018